United States · FDA National Drug Code directory
SUBVENITE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69102-418_3e1f8823-3330-41e3-a385-3f65d45a1bca
- Product NDC
- 69102-418
- Form
- SUSPENSION
- Composition / generic term
- LAMOTRIGINE
- Labeler
- OWP Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20251001
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMOTRIGINE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 PACKAGE (69102-418-01) / 240 mL in 1 BOTTLE · 69102-418-01
- 2 BOTTLE in 1 PACKAGE (69102-418-02) / 240 mL in 1 BOTTLE · 69102-418-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →